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In the present study, we demonstrate that Ca
2þ-induced growth inhibition and induction of differentiation in a line of human colon
carcinoma cells (CBS) is dependent on mitogen-activated protein (MAP) kinase signaling and is associated with upregulation of
extracellular calcium-sensing receptor (CaSR) expression. When CBS cells were grown in Ca
2þ-free medium and then switched to
medium supplemented with 1.4mM Ca
2þ, proliferation was reduced and morphologic features of differentiation were expressed.
E-cadherin, which was minimally expressed in nonsupplemented medium, was rapidly induced in response to Ca
2þ stimulation.
Sustained activation of the extracellular signal-regulated kinase (ERK) occured in Ca
2þ-supplemented medium. When an inhibitor
of ERK activation (10mM U0126) was included in the Ca
2þ-supplemented culture medium, ERK-activation did not occur.
Concomitantly, E-cadherin was not induced, cell proliferation remained high and differentiation was not observed. The same level of
Ca
2þ supplementation that induced MAP kinase activation also stimulated CaSR upregulation in CBS cells. A clonal isolate of the
CBS line that did not upregulate CaSR expression in response to extracellular Ca
2þ was isolated from the parent cells. This isolate
failed to produce E-cadherin or undergo growth inhibition/induction of differentiation when exposed to Ca
2þ in the culture medium.
However, ERK-activation occurred as efficiently in this isolate as in parent CBS cells or in a cloned isolate that underwent growth
reduction and differentiation in response to Ca
2þ stimulation. Together, these data indicate that CaSR upregulation and MAP kinase
signalling are both intermediates in the control of colon carcinoma cell growth and differentiation. They appear to function, at least in
part, independently of one another.
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Calcium (Ca
2þ) has growth-inhibiting and differentiation-pro-
moting activities for a variety of normal and malignant epithelial
cells, including cells of the gastrointestinal tract (Lamprecht and
Lipkin, 2003). Compelling experimental and epidemiological
evidence suggests an inverse relationship between dietary intake
of Ca
2þ and risk of colorectal cancer (Sellers et al, 1998; Baron
et al, 1999; Lipkin, 1999; Kampman et al, 2000; Wargovich et al,
2000; Wu et al, 2002; McCullough et al, 2003). Although such
findings strongly imply a role for extracellular Ca
2þ in regulating
growth and differentiation in colon epithelium, the mechanism(s)
by which this occur(s) is/are poorly understood.
Recent studies suggest that the extracellular calcium-sensing
receptor (CaSR) is involved in the regulation of colon carcinoma
cell growth and differentiation (Chakrabarty et al, 2003, 2005). The
CaSR is expressed in a number of human colon carcinoma cell
lines derived from moderately-differentiated tumours. The CaSR
promoter has two distinct Ca
2þ-responsive sites and exposure of
colon carcinoma cells to extracellular Ca
2þ upregulates CaSR
expression. That CaSR expression might be critical to the growth-
reduction and differentiation-induction by Ca
2þ in these cells is
suggested by the finding that gadolinium (Gd
3þ), an analogue of
Ca
2þ which binds to the CaSR but does not enter cells (Garrett
et al, 1995; Hebert and Brown, 1995; Rutten et al, 1999), is equally
efficient as Ca
2þ in reducing growth and inducing differentiation
(Chakrabarty et al, 2003).
The present studies further our efforts to understand mecha-
nisms of growth regulation in colon epithelium by extracellular
Ca
2þ. Here, we show that the extracellular signal-regulated kinase
(ERK) cascade of the mitogen-activated protein (MAP) kinase
family is activated in a sustained fashion by extracellular Ca
2þ in a
line of colon carcinoma cells (CBS), concomitant with growth
suppression and induction of differentiation. Interference with
ERK activation using the inhibitor U0126 prevents Ca
2þ-induced
alterations in growth and differentiation. A CBS clone that fails
to upregulate CaSR in response to Ca
2þ also fails to demonstrate
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sgrowth reduction or induction of differentiation under the same
conditions. However, when the CaSR-defective cells are exposed
to extracellular Ca
2þ, ERK activation occurs as efficiently as in the
parent cells. Taken together, these data indicate that both CaSR
upregulation and MAP kinase signalling are critical intermediates in
the control of colon carcinoma cell growth and differentiation. The
two events appear to be (at least in part) independent of each other.
MATERIALS AND METHODS
Reagents
Reagents used in these studies included antibodies to the total and
phosphorylated forms of ERK, obtained from Cell Signaling
Technologies Inc.; Beverly, MA, USA; antibody to E-cadherin,
obtained from Chemicon International Inc., Temecula, CA, USA;
antibody to CaSR, obtained from Alpha Diagnostic International,
San Antonio, TX, USA; and antibody to b-tubulin, obtained from
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA. Signalling
inhibitors included U0126 (ERK inhibitor), obtained from Cell
Signaling Technologies Inc. (Favata et al, 1998); SB203580 (P38
inhibitor), obtained from Calbiochem, San Diego, CA, USA, (Moon
et al, 2002); SP600125, an anthrapyrazolone inhibitor of the
Jun-N-terminal kinase (JNK) obtained from Axxora LLC, San Diego,
CA, USA (Bennett et al, 2001); and LY294002, an inhibitor of
phosphatidylinositol-3-kinaase (PI3K) obtained from Cell Signal-
ing Technologies (Panka et al, 2001).
Cell culture
The moderately-differentiated colon carcinoma cell line, CBS, was
used in these studies. This cell line was described in our past
reports dealing with CaSR expression and colon carcinoma growth
control (Chakrabarty et al, 2003, 2005). The cells were maintained
in Ca
2þ-free minimal essential medium – Spinner modified
(SMEM) (Sigma Chemical Co., St Louis, MO, USA) supplemented
with sodium bicarbonate, amino acids, and 5% foetal bovine
serum (FBS). Growth was at 371C in an atmosphere of 95% air and
5% CO2. Cells were subcultured by brief exposure to trypsin/EDTA
solution.
Random cell cloning was used to obtain several isolates of the
CBS line. Briefly, a single-cell suspension of the parent cells was
fractionated using a flow cytometer (Facscan, Becton-Dickinson)
and one cell per well deposited into wells of a 96-well dish
containing 100ml of CBS-conditioned medium. When individual
colonies were of sufficient size, they were subcultured into 25-cm
2
flasks. When the flasks reached confluence, there were sufficient
cells for use in experiments. Cloned isolates were maintained
exactly as the parent cells.
Cell proliferation assay
Cells were plated in 24-well tissue culture dishes at 4 10
4 cells per
well using Ca
2þ-free SMEM with 5% FBS as culture medium. After
allowing the cells to attach overnight, they were washed twice with
Ca
2þ-free SMEM without FBS and then incubated in Ca
2þ-free
SMEM with 5% dialysed FBS. Different amounts of Ca
2þ were then
added to individual wells as indicated in the Results. Proliferation
was measured by releasing the cells with trypsin/EDTA and
enumerating them using a particle counter (Coulter Electronics,
Hialeah, FL, USA). For dose–response studies, cells were harvested
on day-3. For time-course studies, cell counts were made on days
1–4.
Immunohistochemistry
Immunoperoxidase staining for E-cadherin was performed as
described previously using formalin-fixed CBS cells (Sheinin et al,
2000; Chakrabarty et al, 2003). The immunoperoxidase reaction
product was visualised using diaminobenzidine as the chromo-
genic substrate. Immunostained sections were lightly counter-
stained with haematoxylin and examined by light microscopy.
Preparation of cell lysates and immunoblot analysis
CBS cells were plated at 3 10
5 cells per well in wells of a six-well
dish using Ca
2þ-free SMEM with 5% FBS as culture medium. The
cells were allowed to attach overnight. The next day, they were
washed and then incubated in Ca
2þ-free SMEM with 5% dialysed
FBS with or without Ca
2þ (1.4mM). After incubation for the
desired amount of time, cells were lysed in 1  cell lysis buffer
consisting of 20mM Tris-HCl (pH 7.4), 2mM sodium vanadate,
1.0mM sodium fluoride, 100mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 25mgml
 1 each aprotinin, leupeptin and pepstatin,
and 2mM EDTA and EGTA. Lysis was performed at 41Cb y
scraping the cells into lysis buffer and sonicating the samples.
Cell lysates were incubated on ice for 15min and then cleared by
microcentrifugation at 16000g for 15min. The supernatant fluids
were collected and protein concentration was estimated using the
BioRad DC protein assay kit (BioRad, Hercules, CA, USA).
Cell extracts containing equivalent amounts of protein (40mgo f
total protein per lane) were examined by Western blotting for
E-cadherin, CaSR, and signalling intermediates (total and phos-
phorylated forms of ERK) using procedures described previously
(Bhagavathula et al, 2004). Briefly, samples were separated in SDS-
PAGE under denaturing and reducing conditions and transferred
to nitrocellulose membranes. After blocking with a 5% nonfat milk
solution in Tris-buffered saline with 0.1% Tween (TTBS) at 41C
overnight, membranes were incubated for 1h at room temperature
with the desired antibody, diluted 1:1000 in 0.5% nonfat milk/
0.1% TTBS. Thereafter, the membranes were washed with TTBS
and bound antibody detected using the Phototope-HRP Western
blot detection kit (Cell Signaling Technologies Inc.). Images were
scanned, digitised and quantified using NIH image analysis
software.
Statistical analysis
Data from studies with multiple experiments and multiple samples
per data point were expressed as mean7s.e. Data from studies
with multiple experiments and one sample per data point in each
experiment (Western blot experiments) were expressed as
mean7s..d. For experiments in which multiple groups were
included, statistical analyses were carried out by ANOVA followed
by paired group comparisons. For experiments in which two
groups were compared to one another, the Student’s t-test was
used. Po0.05 was considered statistically significant.
RESULTS
Effect of extracellular Ca
2þ on proliferation of CBS colon
cancer cells
Initially, the effects of different extracellular Ca
2þ levels on
proliferation of CBS cells was studied. As shown in Figure 1 (upper
panel) inhibition of CBS cell proliferation was dose-dependent
between 0 and 1.4mM extracellular Ca
2þ. Growth was inhibited by
approximately 45% in the presence of 1.4mM Ca
2þ. As shown in
the lower panel of Figure 1, minimal (not statistically significant)
inhibition of growth was observed 1 day after shifting the cells
to Ca
2þ (1.4mM)-supplemented medium. Statistically significant
inhibition was observed on days 2–4. A change in the morpho-
logical appearance of the cells accompanied Ca
2þ-induced growth
inhibition. Whereas CBS cells grew in small, grape-like clusters
under low-Ca
2þ conditions, they became flattened in the presence
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2þ-supplemented medium (see Figure 2, upper panel for
example).
Ca
2þ-mediated changes in CBS cell proliferation:
dependence on ERK-activation
Following the observation of growth inhibition with increasing
concentrations of exogenous Ca
2þ, we next sought to identify
critical intermediary events leading from Ca
2þ stimulation to
reduced growth. Figure 2 shows effects of the ERK-activation
inhibitor U0126 on CBS cell proliferation as well as on
morphological appearance in the presence of high (1.4mM)
extracellular Ca
2þ. As compared to cells maintained in
SMEMþdialysed FBS (without Ca
2þ supplementation) through-
out the 3-day incubation period, a reduction in cell growth was
observed in the presence of 1.4mM Ca
2þ. Concomitantly, cells
maintained in Ca
2þ-supplemented medium underwent a change
in morphological appearance (i.e. increased flattening) consistent
with differentiation. Both the suppression of proliferation and
induction of differentiated features were substantially reversed
when U0126 (10mM) was included in the culture medium
throughout the incubation period. These data indicate that Ca
2þ
modulation of growth and differentiation occurs in a MAP kinase-
dependent manner.
Effects of extracellular Ca
2þ and U0126 on E-cadherin
expression
The homotypic cell–cell adhesion molecule E-cadherin functions
as a tumour suppressor in colon carcinoma cells, and upregulation
of E-cadherin expression is associated with the induction of
differentiation in these cells (Wang and Chakrabarty, 2001; Van
Aken et al, 2001). We examined the effect of extracellular Ca
2þ on
the expression of E-cadherin both by immunostaining and
immunoblotting techniques. As shown in Figure 3 (upper panel),
cells cultured in Ca
2þ-free SMEM plus dialysed FBS for 3 days
showed little or no staining for E-cadherin. However, cells grown
in the same medium supplemented with 1.4mM Ca
2þ showed
significant E-cadherin expression. It could be seen that much of
the reactivity in the presence of Ca
2þ was at the cell periphery.
When cell lysates were prepared and expression of E-cadherin
assessed by Western blotting, a 3.5-fold increase in the expression
of E-cadherin was observed in cells grown in Ca
2þ-supplemented
medium as compared to the cells grown in Ca
2þ-free medium
(Figure 3, lower panel). When U0126 (10mM) was included
in Ca
2þ-supplemented medium, increased E-cadherin expression
was largely abolished (Figure 3, upper and lower panels). These
observations demonstrate that E-cadherin expression increases
in response to extracellular Ca
2þ in a MAP kinase-dependent
manner.
In addition to using U0126 to interfere with activation through
the ERK pathway, we also utilised inhibitors to block signalling
through two other MAP kinase pathways (P38 and JNK) as well
as signalling through the PI3K/Akt pathway. When CBS cells were
treated with the P38 inhibitor, SB203580 (15mM), there was no
effect on cell growth under low-Ca
2þ conditions and only a
modest (not statistically significant) increase in proliferation
compared to control cells in high-Ca
2þ medium (Figure 4).
Consistent with this, there was an increased expression of
E-cadherin in both control and SB203580-treated cells under
high-Ca
2þ conditions compared to cells in low-Ca
2þ conditions.
In contrast, there was no significant difference in E-cadherin
expression between control and SB203580-treated cells (under
either condition) (Figure 4). Results with the other two inhibitors
were considerably different. Both the JNK inhibitor (SP600125;
0.1mM) and the PI3K inhibitor (LY294002; 30mM) strongly
inhibited proliferation of CBS cells under low-Ca
2þ conditions
but little effect under high-Ca
2þ conditions (Figure 4). Consistent
with growth-inhibition under low-Ca
2þ conditions was a slight
increase in E-cadherin expression with both agents. Also
consistent, the high level of E-cadherin expressed in Ca
2þ-
supplemented medium was not further increased by either agent
(Figure 4).
Effects of U0126 on CaSR expression
Since the effects of extracellular Ca
2þ on CBS growth and
differentiation appeared to involve ERK activation, experiments
were conducted to determine if the same treatment influenced
CaSR expression. Consistent with our recent studies (Chakrabarty
et al, 2003, 2005), CaSR was detected in CBS cells maintained for
3 days in Ca
2þ-free medium (SMEMþdialysed FBS), but the
expression level was low. When the extracellular Ca
2þ concentra-
tion was increased to 1.4mM, expression of CaSR was substantially
increased (Figure 5). Of interest, upregulation of CaSR expression
did not appear to depend on ERK signalling since cells incubated
in Ca
2þ-supplemented medium containing 10mM U0126 showed
the same upregulation as cells maintained in the absence of the
inhibitor (Figure 5).
Effect of extracellular Ca
2þ on expression of
phosphorylated-ERK
Next, CBS cells were incubated for 1 day in SMEM with dialysed
FBS with or without Ca
2þ and treated with U0126. Lysates were
prepared from the cells at various times after treatment and
probed for phosphorylated ERK and total ERK protein expression.
As shown in Figure 6, there was no effect on ERK phosphorylation
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Figure 1 Effect of extracellular Ca
2þ on proliferation of CBS colon
cancer cells. Upper panel: dose–response. Lower panel: time–response.
Values shown are means and s.d. based on triplicate samples in a single
experiment. Statistical significance was determined by ANOVA, followed
by paired group comparisons or by Student’s t-test. * indicates differences
from control group (no Ca
2þ supplementation) at the Po0.05 level. Both
proliferation studies were conducted five times with consistent results.
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s5min after exposure to extracellular Ca
2þ but an increase was
observed at 15 and 30min post-treatment. ERK phosphorylation
remained elevated through 1 day. When lysates prepared from
cells treated with 10mM U0126 in Ca
2þ-supplemented medium
were examined, ERK-phosphorylation was reduced to below basal
level. Neither Ca
2þ-supplementation nor U0126 had a measurable
effect on total ERK protein levels (Figure 6).
Differences in Ca
2þ sensitivity among cloned CBS isolates
In all, 12 separate isolates of randomly-cloned CBS cells were
incubated in duplicate wells. One well of each duplicate was
maintained in Ca
2þ-free SMEM (plus dialysed FBS) while the
other was incubated in the same culture medium supplemented
with extracellular Ca
2þ to a final concentration of 1.4mM. After 3
days, lysates were prepared from cells in each well and examined
for E-cadherin expression by Western blotting. In none of the
12 isolates was there significant E-cadherin expression in the
absence of Ca
2þ-supplementation. In Ca
2þ-supplemented
medium, six of the isolates expressed high levels of E-cadherin
while in the other six isolates there was little or no E-cadherin
expression. Western blots from representative Ca
2þ-responsive
and -nonresponsive isolates (termed R1 and NR1, respectively)
are shown in Figure 7 (upper panel). Not surprising, the isolate
that expressed E-cadherin in response to Ca
2þ-stimulation
underwent morphological differentiation in Ca
2þ-supplemented
medium and demonstrated reduced growth as compared to cells
in nonsupplemented medium (46% inhibition; n¼3; Po0.05
by Student’s t-test). In contrast, the cells that did not express
E-cadherin in response to Ca
2þ-stimulation failed to differentiate
(morphologically) in Ca
2þ-supplemented medium and did not
demonstrate a significant reduction in growth (4% reduction
relative to nonsupplemented medium; n¼3; ns by Student’s
t-test).
The same Ca
2þ-responsive isolate R1 and Ca
2þ-nonresponsive
isolate NR1 were maintained for 3 days in SMEM plus dialyzed FBS
with or without added Ca
2þ. At the end of the incubation period,
lysates were prepared and examined for CaSR expression by
Western blotting. Both isolates expressed detectable levels of CaSR.
In nonsupplemented medium, the levels expressed by the two
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Figure 2 Effect of U0126 on extracellular Ca
2þ-mediated changes in CBS cell growth and differentiation. Upper panel: morphological appearance of CBS
cells grown for 3 days in Ca
2þ-free medium with or without 10mM U0126 (upper left and upper right respectively) or in medium supplemented with 1.4mM
Ca
2þ with or without 10mM U0126 (lower left and lower right). Lower panel: CBS cell proliferation under the same conditions. Values shown are means and
s.d. based on triplicate samples in a single experiment. Statistical significance was determined by ANOVA, followed by paired group comparisons. * indicates
differences from high-Ca
2þ group (1.4mM Ca
2þ supplementation) at the Po0.05 level. The study was conducted five times with consistent results.
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Figure 3 Effect of extracellular Ca
2þ and U0126 on E-cadherin expression. Upper panel: E-cadherin expression by immunostaining of CBS cells grown for
three days in nonsupplemented medium (left), in medium supplemented with 1.4mM Ca
2þ (centre) and in medium supplemented with 1.4mM Ca
2þ and
10mM U0126 (right). Lower panel: E-cadherin expression by Western blotting (same conditions). Quantitative values are based on densitometry scanning
of bands in four separate experiments and are means and s.d. Statistical significance was determined by ANOVA, followed by paired group comparisons.
*indicates differences from high-Ca
2þ group (1.4mM Ca
2þ supplementation) at the Po0.05 level.
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Figure 4 Effect of P38, JNK and PI3K inhibitors on CBS cell growth and
E-cadherin expression under low-Ca
2þ and high-Ca
2þ conditions. Upper
panel: CBS cell proliferation. Values shown are means and s.d. based on
quadruplicate samples in duplicate experiments. Statistical significance was
determined by ANOVA, followed by paired group comparisons. * indicates
differences from the respective low-Ca
2þ or high-Ca
2þ control groups at
the Po0.05 level. Lower panel: E-cadherin expression and b-tubulin
expression by Western blotting (same conditions). Western blots were
conducted in three separate experiments with consistent results.
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Figure 5 Effect of extracellular Ca
2þ and U0126 on CaSR expression.
Western blotting for CaSR expression in CBS cells grown for three days in
nonsupplemented medium (left), in medium supplemented with 1.4mM
Ca
2þ (centre) and in medium supplemented with 1.4mM Ca
2þ and 10mM
U0126 (right). Quantitative values are based on densitometry scanning of
bands in four separate experiments and are means and s.d. Statistical
significance was determined by ANOVA, followed by paired group
comparisons.
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sisolates were similar to the level expressed by the uncloned parent
population (Figure 7, middle panel). In Ca
2þ-supplemented
medium, however, differences were observed. Specifically, isolate
R1 showed the same upregulation of CaSR as the parent cells
(compare Figure 7, middle panel with Figure 5). In contrast, isolate
NR1 failed to upregulate CaSR under the same conditions (Figure 7,
middle panel).
In a final set of experiments, the phosphorylation pattern of
ERK was assessed in R1 and NR1 isolates grown for 1 day in SMEM
plus dialysed FBS with or without added Ca
2þ. As shown in the
lower panel of Figure 7, there was a significant increase in ERK
phosphorylation in Ca
2þ-supplemented medium in both isolates,
as compared to what was seen in nonsupplemented medium. There
were no differences in the total ERK protein levels between
the two isolates under either condition. Not surprisingly, U0126
(10mM) suppressed levels of phosphorylated ERK to below baseline
levels in both isolates in Ca
2þ-supplemented medium
(not shown).
DISCUSSION
Extracellular Ca
2þ is a critical regulator of epithelial cell growth
and differentiation, but the mechanistic events that lead from an
increase in extracellular Ca
2þ to growth inhibition and onset of
differentiation are not fully understood. Induction of E-cadherin is
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Figure 6 Effect of extracellular Ca
2þ and U0126 on expression of
phosphorylated-ERK. Upper panel: time-course for Ca
2þ-induced ERK
phosphorylation. Lysates were prepared from CBS cells at various times
after exposure to Ca
2þ and analysed for phosphorylated-ERK by Western
blotting. Lower panel: inhibition of Ca
2þ-induced ERK phosphorylation in
the presence of U0126. CBS cells were grown for 1 day in Ca
2þ-free
medium (left), in medium supplemented with 1.4mM Ca
2þ (centre) and in
medium supplemented with 1.4mM Ca
2þ and 10mM U0126 (right).
Lysates were prepared and analysed for ERK phosphorylation by Western
blotting. Quantitative values are based on densitometry scanning of bands
in four separate experiments and are means and s.d. Statistical significance
was determined by ANOVA, followed by paired group comparisons. In
upper panel, * indicates difference from zero-time value at Po0.05 level. In
lower panel, * indicates differences from high-Ca
2þ group (1.4mM Ca
2þ
supplementation) at the Po0.05 level.
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Figure 7 Effect of extracellular Ca
2þ on E-Cadherin, CaSR, and
phosphorylated-ERK expression in Ca
2þ-responsive and nonresponsive
CBS clones. Upper panel: E-cadherin expression; Middle panel: CaSR
expression; Lower panel: ERK expression. R1 and NR1 isolates of CBS cells
were grown for three days in Ca
2þ-free medium (left) and in medium
supplemented with 1.4mM Ca
2þ (right). Western blotting was used to
assess the proteins. Quantitative values are based on densitometry scanning
of bands in three separate experiments and are means and s.d. Statistical
significance was determined by Student’s t-test, comparing nonsupplemen-
ted and Ca
2þ-supplemented conditions for the two isolates separately.
*indicates differences from the nonsupplemented medium at the Po0.05
level.
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sknown to be important. E-cadherin is minimally expressed
in rapidly-growing epithelial cells in vitro but is upregulated
during differentiation (Birchmeier 1995; Mareel et al, 1996).
In vivo, the loss of E-cadherin from the cell surface occurs
during tumour progression to a more malignant phenotype
(Birchmeier 1995; Mareel et al, 1996; Van Aken et al, 2001). This
occurs in conjunction with a loss of differentiated histological
features. In recent studies, we demonstrated that Ca
2þ-induced
growth arrest and differentiation in CBS colon carcinoma cells
were associated with E-cadherin elaboration and, ultimately, with
cell surface E-cadherin expression. Among the events associated
with E-cadherin accumulation in the membrane was a reduction
in intra-nuclear complexes of b-catenin/TCF4 (possibly due to
competition of surface E-cadherin for b-catenin) and down-
regulation of TCF4 transcription. Additional events associated with
Ca
2þ treatment in CBS cells included increased production of the
cell cycle inhibitors P21 and P27, increased g-catenin expression
and increased cytokeratin expression (Chakrabarty et al, 2003,
2005; Giles et al, 2003; Kamei et al, 2003). These changes, alone or
in combination, may ultimately be responsible for the growth-
suppression and onset of differentiation seen in the colon
epithelial cells.
The present study provides evidence that MAP kinase signalling
and CaSR upregulation are both critically involved as upstream
regulators of Ca
2þ-induced E-cadherin expression (and the
subsequent changes in growth and differentiation) in cells
derived from human colon cancer. The two events appear
to be, at least in part, independent of one another. Using a line
of colon carcinoma cells, we found that cells equilibrated in
Ca
2þ-free medium and then exposed to 1.4mM Ca
2þ underwent a
(relatively) slow but sustained rise in phosphorylated ERK. The
same conditions that led to a rise in ERK phosphorylation
(activation) also resulted in expression of E-cadherin and with
reduced growth and increased differentiation. U0126, a potent
inhibitor of MEK-dependent ERK-activation, prevented Ca
2þ-
induced E-cadherin expression. Concomitantly, the reduction in
cell proliferation and onset of differentiation normally seen in
Ca
2þ-supplemented medium did not occur. U0126 was effective at
10mM, a concentration at which the inhibitor is known to be highly
specific for MEK-dependent ERK activation (Favata et al, 1998).
Inhibitors of three other signalling pathways did not duplicate
these effects.
The ERK family of MAP kinases consists of a cascade of
intracellular signalling elements that respond to a number of
extracellular stimuli, including soluble peptide growth factors and
components of the extracellular matrix. Peptide growth factors
induce a sharp rise in activation (20–50-fold over baseline).
Activation tends to be rapid (peaks within 2–5min) and transient,
with the active kinases falling to some intermediate level within
15–30min. Under such conditions, a proliferative response is seen
(Zheng et al, 1994; Chen et al, 1996; Zeigler et al, 1999). MAP
kinase activation following cell contact with the extracellular
matrix (integrin-mediated) results in a smaller increase (in the
range of 2–6-fold increase over baseline) but the response is
sustained. MAP kinase activation in this manner is associated with
a differentiation response rather than with proliferation (Marshall,
1995).
Only a relatively few previous studies have addressed the
relationship between MAP kinase signalling and E-cadherin
expression. The data are complex and seemingly inconsistent.
In one recent study, a switch from low- to high- extracellular
Ca
2þ was shown to induce ERK activation in an immortalised
epidermal keratinocyte line (Pece and Gutkind, 2000) – similar to
what we have observed here. In that study, however, E-cadherin
was purposed to be a critical intermediate in the MAP
kinase activation sequence since disruption of E-cadherin
function with an anti-E-cadherin antibody prevented the rise in
MAP kinase signalling. In another study, epithelial cells were
maintained under sparse conditions (undifferentiated state)
or in dense culture (where differentiation occurred) and
examined for ERK expression. Cells in sparse culture expressed
high levels of phosphorylated ERK relative to what was seen in
dense culture. In the presence of an ERK inhibitor (PD98059),
levels of phosphorylated ERK were reduced. Concomitantly, E-
cadherin expression was increased (Conacci-Sorrell et al, 2003).
Based on this, it was concluded that ERK activation was
responsible for suppression of E-cadherin, and for preventing
differentiation in sparse culture. In yet another study, MAP kinase
blockade was found to suppress growth of colon tumours in vivo
(Sebolt-Leopold et al, 1999). Presumably, growth suppression
in vivo reflected interference with signals generated via interaction
of cell surface receptors with peptide growth factors. While our
data do not conflict, a priori, with these previous observations, it is
clear from the present study that in the CBS colon carcinoma cells,
MAP kinase activation is a critical component in the sequence
of events that leads from extracellular Ca
2þ stimulation to the
induction of E-cadherin, and, ultimately, to growth suppression
and onset of differentiation. Based on the previous findings of
others (reviewed in Alpin et al, 1998), we can suggest that
interaction of CBS colon carcinoma cells with components of the
extracellular matrix constitutes the initial stimulus for ERK
activation and the subsequent downstream events (including,
presumably, E-cadherin expression) that follow. While direct
evidence to support this hypothesis is lacking, what is clear
is that in CBS cells, ERK activation is upstream in the sequence of
events that lead from Ca
2þ stimulation to growth arrest and
differentiation.
Induction of CaSR appears to be a second critical event leading
from Ca
2þ stimulation to growth arrest and differentiation. This is
based on the observation that in the mixed population of parental
CBS cells, there are cells that do not respond to Ca
2þ stimulation
with the expected induction of E-cadherin or in growth-retarda-
tion. When these cells were isolated and cloned, they also failed
to demonstrate upregulation of CaSR in response to Ca
2þ
stimulation. How Ca
2þ stimulation leads to CaSR induction is
not fully understood. The CaSR gene has promoter regions that are
sensitive to both Ca
2þ and vitamin D (Canaff and Hendy 2002).
Response elements for the two agonists are different, such that a
mutation in one site can affect binding of one agonist without
affecting the other (Chakrabarty et al, 2005). Studies are underway
at present to determine if clones of CBS cells that do not undergo
growth arrest or differentiation in response to Ca
2þ stimulation
have defects in the Ca
2þ-binding region of the CaSR promoter. If
Ca
2þ is a direct activator of CaSR, one would predict (consistent
with what we have observed) that downstream signalling events
would not be required for induction. Additional studies will be
needed to verify this suggestion and to fully explore the
mechanism of Ca
2þ-induced CaSR expression.
The findings in the present report are based on studies in a
single line of moderately-differentiated human colon carcinoma
cells. However, our findings are probably not unique to these cells.
In a recent study, we showed that in four different human colon
carcinoma cell lines (including CBS), raising the extracellular Ca
2þ
concentration resulted in induction of E-cadherin and inhibition
of growth (Chakrabarty et al, 2003). A direct relationship between
CaSR expression and the differentiated phenotype has also been
observed in both the normal colonic mucosa and malignant
colonic epithelium (Sheinin et al, 2000; Chakrabarty et al, 2003,
2005).
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